Macrogen, Inc. engages in the provision genetic research and biotechnology services. Its services include genome sequencing, oligonucleotide, microarray, genetically engineered mouse, clinical sequencing, and personal genome sequencing. The company was founded on June 5, 1997 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company